Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Type 2 Diabetes Mellitus Treatment Companies

ID: MRFR/Pharma/4214-HCR
85 Pages
Satyendra Maurya
Last Updated: May 15, 2026
Companies involved in the treatment of Type 2 Diabetes Mellitus (T2DM) cover a broad spectrum, including pharmaceuticals, medical devices, and healthcare services.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the Type 2 Diabetes Mellitus Treatment Market

Type 2 Diabetes Mellitus Treatment Key Companies
 
Latest Type 2 Diabetes Mellitus Treatment Companies Update

Eli Lilly Announced positive Phase 3 trial results for its GLP-1 receptor agonist Tirzepatide, demonstrating superior blood sugar control and weight loss compared to existing drugs.

Novo Nordisk Received FDA approval for its dual SGLT2/GLP-1 agonist Ozempic®, offering a new option for patients with inadequate glycemic control on other medications.

Boehringer Ingelheim Partnered with Eli Lilly to co-develop and commercialize their next-generation SGLT2 inhibitor Jardiance®, aiming to expand their reach in the diabetes market.

List of Type 2 Diabetes Mellitus Treatment Key Companies in the Market

  • Abbott Laboratories
  • Acon Laboratories Inc.
  • Adocia
  • Akros Pharma
  • Amgen
  • AstraZeneca
  • Bayer AG
  • Becton
  • Dickinson and Company
  • Biocon
  • Boehringer Ingelheim
  • Daiichi Sankyo
  • Eli Lilly
  • Merck
  • Novartis & Co.
  • Novo Nordisk
  • Peptron
  • Pfizer
  • Roche Diagnostics Ltd.
  • Sanofi
  • Sunpharma
  • Takeda Pharmaceuticals